Year: 2025
ROCHESTER, N.Y., March 07, 2025 (GLOBE NEWSWIRE) — Vaccinex, Inc. (OTC: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease by blocking astrogliosis and neuroinflammation through the inhibition of SEMA4D, today announced that it has notified the Nasdaq Stock Market (“Nasdaq”) of its decision to delist the Company’s shares of common stock, par value $0.0001 per share (the “Common Stock”), from Nasdaq. Trading in the Common Stock on Nasdaq has been suspended since December 18, 2024.
Vaccinex intends to file a Form 25 with the Securities and Exchange Commission on or about March 17, 2025 to remove its Common Stock from listing on Nasdaq.
The Company’s decision to delist follows its receipt of notice dated December 16, 2024, that the...
Orezone Gold Files Final Short Form Prospectus in Connection With C$35 Million Bought Deal
Written by Customer Service on . Posted in Public Companies.
Final Short Form Prospectus is accessible on SEDAR+
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
VANCOUVER, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased to announce that, further to its press release dated February 23, 2025 in respect of its bought deal offering of common shares of the Company (the “Common Shares”), it has filed a final short form prospectus dated March 7, 2025 (the “Final Prospectus”) with the securities commissions in all provinces of Canada, except Quebec, and has obtained a receipt therefor.
The Final Prospectus qualifies the distribution of 42,683,000 Common Shares at a price of C$0.82 per Common Share (the “Offering Price”) for aggregate gross proceeds of C$35,000,060...
Methanex Releases 2024 Sustainability Report
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) — Methanex Corporation (TSX:MX) (Nasdaq:MEOH) released its 2024 Sustainability Report today to share its progress on the sustainability topics that are most material to the company and its stakeholders.
“I am proud of our global team’s commitment to safety and Responsible Care® and our best-ever safety performance achievement in 2024. Our safety performance puts us in the top ten per cent for safety performance among the American Chemistry Council’s Responsible Care members.1 The Sustainability Report outlines Methanex’s 2024 activities, including how we protect and develop our people, minimize our impact on the environment and contribute to our communities.” said Rich Sumner, President and CEO of Methanex. “I am pleased to report on our progress towards fulfilling our...
Grupo Aeroportuario del Pacifico, S.A.B. de C.V. General Ordinary Shareholders’ Meeting
Written by Customer Service on . Posted in Public Companies.
GUADALAJARA, Mexico, March 07, 2025 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announced the following:
Pursuant to a resolution adopted by our board of directors on February 24, 2025, and in accordance with Articles 180, 181, 182 and other applicable articles of the Mexican General Corporate Law and Article 35 of the Company’s by-laws, Grupo Aeroportuario del Pacífico, S.A.B. de C.V. invites its shareholders to the General Ordinary Shareholders’ Meeting on April 24, 2025 at 12:00 p.m. in Ballroom 3, 3rd floor of the Hilton Midtown Hotel, located at Av. López Mateos 2405-300, Col. Italia Providencia, Guadalajara, Jalisco, Mexico, to discuss the following:
ANNUAL GENERAL ORDINARY SHAREHOLDERS’ MEETINGAGENDA
I. In compliance with Article 28, Section IV of the...
Constellation Software Inc. Announces Results for the Fourth Quarter and Year Ended December 31, 2024 and Declares Quarterly Dividend
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
TORONTO, March 07, 2025 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) (“Constellation” or the “Company”) today announced its financial results for the fourth quarter and year ended December 31, 2024 and declared a $1.00 per share dividend payable on April 15, 2025 to all common shareholders of record at close of business on March 28, 2025. This dividend has been designated as an eligible dividend for the purposes of the Income Tax Act (Canada). Please note that all dollar amounts referred to in this press release are in U.S. Dollars unless otherwise stated.
The following press release should be read in conjunction with the Company’s annual Consolidated Financial Statements, prepared in accordance with IFRS Accounting Standards (“IFRS”) and our annual Management’s Discussion and Analysis for the year ended December 31,...
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the fourth quarter and full year ended December 31, 2024.
“We expect to receive 24-week topline data from our Phase 2b ASPIRE study in diabetic macular edema (DME) in this quarter,” said Anirvan Ghosh, Ph.D., chief executive officer of UNITY. “DME remains a significant unmet need, and we believe UBX1325 (foselutoclax) has the potential to provide a differentiated treatment option for patients who continue to experience vision loss despite current standard-of-care therapies. With its novel mechanism of action and durable therapeutic profile, UBX1325 could offer meaningful advantages over existing anti-VEGF...
Blueberries Medical Announces C$1 Million Non-Brokered Private Placement
Written by Customer Service on . Posted in Public Companies.
TORONTO, March 07, 2025 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce a non-brokered private placement consisting of the sale of 96,064,935 common shares (“Common Shares”) at a price of C$0.011 per Common Share for aggregate gross proceeds of approximately C$1.05 million (or approximately US$740,000) (the “Offering”). The net proceeds from the sale of the Common Shares are expected to fund and expand operations, for general corporate and working capital purposes. The Offering is expected to close on or about March 25, 2024.
It is expected that the Offering will be led by Terraflos Inc. (“Terraflos”), a cannabis company with operations throughout...
S&P Global Ratings affirms Iceland at ‘A+/A-1’, Outlook Stable
Written by Customer Service on . Posted in Public Companies.
S&P Global Ratings has affirmed ‘A+/A-1’ long- and short-term foreign and local currency sovereign credit ratings on Iceland. The outlook is stable.
S&P´s ratings on Iceland reflect the country’s very high GDP per capita and strong growth track record, which has been higher than most sovereigns S&P rates in Western Europe, as well as Iceland’s robust institutional framework and sound economic and fiscal policies. The ratings remain constrained by the volatile nature of Iceland’s small, open economy, which, in S&P’s view, is vulnerable to natural events, including volcanic activity, as well as adverse external developments outside of its control, such as geopolitical risks, trade and tariff tensions, and fluctuating terms-of-trade. The small size of Iceland’s economy also somewhat limits...
Pennant Group to Participate in the 2025 Oppenheimer Annual Healthcare Conference
Written by Customer Service on . Posted in Public Companies.
EAGLE, Idaho, March 07, 2025 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2025 Oppenheimer Co. Annual Healthcare MedTech & Services Conference on March 18, 2025.
Brent Guerisoli, Chief Executive Officer, Lynette Walbom, Chief Financial Officer, and Kirk Cheney, Executive Vice President, will participate in a fireside chat on March 18, 2025 at 10:00 a.m. Eastern Time. A live webcast of the event will be accessible at the following address: investor.pennantgroup.com/events-and-presentations.
About Pennant:
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 131 home health and hospice...
Canoe EIT Income Fund Announces March 2025 Monthly Distribution
Written by Customer Service on . Posted in Dividend Reports And Estimates.
CALGARY, Alberta, March 07, 2025 (GLOBE NEWSWIRE) — Canoe EIT Income Fund (the “Fund”) (TSX – EIT.UN) announces the March 2025 monthly distribution of $0.10 per unit. Unitholders of record on March 21, 2025, will receive distributions payable on April 15, 2025.
About Canoe EIT Income FundCanoe EIT Income Fund is one of Canada’s largest closed-end investment funds, designed to maximize monthly distributions and capital appreciation by investing in a broadly diversified portfolio of high quality securities. The Fund is listed on the TSX under the symbol EIT.UN, and is actively managed by Robert Taylor, Senior Vice President and Chief Investment Officer, Canoe Financial.
About Canoe Financial Canoe Financial is one of Canada’s fastest growing independent mutual fund companies managing over $19,5 billion in assets across a diversified...